COM:BIOMEAFUSION
Biomea Fusion
- Stock
Last Close
6.38
22/11 21:00
Market Cap
170.74M
Beta: -
Volume Today
490.54K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|
average inventory | ||||||
average payables | 499K - | 1.03M 106.01% | 4.08M 296.64% | 6.84M 67.71% | ||
average receivables | ||||||
book value per share | -0.00 - | 0.48 24,714.29% | 7.49 1,452.34% | 3.71 50.52% | 4.96 33.82% | |
capex per share | -0.00 - | -0.13 2,690.57% | -0.04 73.52% | 0.10 380.81% | ||
capex to depreciation | -6.38 - | -12.73 99.76% | -1.49 88.30% | 2.22 249.23% | ||
capex to operating cash flow | 0.01 - | 0.09 682.34% | 0.02 81.56% | -0.03 311.42% | ||
capex to revenue | ||||||
cash per share | 0.02 - | 5.76 25,713.81% | 8.53 48.06% | 3.91 54.12% | 5.19 32.52% | |
days of inventory on hand | ||||||
days payables outstanding | 595.24 - | |||||
days sales outstanding | ||||||
debt to assets | 0.00 - | 0.02 270.49% | 0.02 15.14% | 0.01 30.20% | ||
debt to equity | 0.05 - | 0.02 68.19% | 0.02 32.06% | 0.01 30.79% | ||
dividend yield | ||||||
earnings yield | -0.01 - | -0.03 343.05% | -0.23 693.33% | -0.32 39.84% | -0.24 26.99% | |
enterprise value | 181.80M - | 120.60M 33.66% | 4.85M 95.98% | 135.65M 2,694.98% | 328.65M 142.28% | |
enterprise value over ebitda | -152.13 - | -22.67 85.10% | -0.12 99.49% | -1.62 1,292.47% | -2.64 62.60% | |
ev to operating cash flow | -142.14 - | -27.05 80.97% | -0.14 99.49% | -2.17 1,486.88% | -3.40 56.56% | |
ev to sales | ||||||
free cash flow per share | -0.12 - | -0.42 252.62% | -1.62 284.22% | -2.17 33.94% | -2.93 35.22% | |
free cash flow yield | -0.01 - | -0.02 252.62% | -0.22 776.74% | -0.26 18.37% | -0.20 21.49% | |
graham net net | -0.00 - | 0.41 9,329.79% | 8.24 1,934.05% | 3.20 61.12% | 4.29 33.77% | |
graham number | 0.07 - | 2.32 3,202.32% | 17.07 634.64% | 15.10 11.51% | 19.59 29.73% | |
income quality | 1.07 - | 0.84 21.55% | 0.85 1.79% | 0.76 10.53% | 0.82 8.00% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | |
interest coverage | 46.31 - | |||||
interest debt per share | 0.02 - | 0.12 393.87% | 0.02 86.30% | 0.07 341.85% | ||
inventory turnover | ||||||
invested capital | 0.05 - | 0.02 68.19% | 0.02 32.06% | 171.19M 813,182,738,018.16% | ||
market cap | 182.04M - | 182.04M 0% | 177.75M 2.36% | 246.76M 38.83% | 495.22M 100.69% | |
net current asset value | -21K - | 4.87M 23,271.43% | 169.64M 3,386.21% | 97.05M 42.79% | 148.49M 53.00% | |
net debt to ebitda | 0.20 - | 11.55 5,675.15% | 4.15 64.08% | 1.33 67.98% | 1.34 0.60% | |
net income per share | -0.11 - | -0.50 343.05% | -1.73 247.66% | -2.73 58.24% | -3.44 25.76% | |
operating cash flow per share | -0.12 - | -0.42 248.63% | -1.49 256.70% | -2.13 43.56% | -2.83 32.82% | |
payables turnover | 0.61 - | |||||
receivables turnover | ||||||
research and ddevelopement to revenue | ||||||
return on tangible assets | -4.53 - | -0.09 98.12% | -0.22 160.81% | -0.62 178.82% | -0.59 5.23% | |
revenue per share | ||||||
roe | 57.19 - | -1.03 101.80% | -0.23 77.60% | -0.74 219.79% | -0.69 6.02% | |
roic | 57.05 - | -0.94 101.65% | -0.22 76.23% | -0.72 222.86% | -0.73 1.59% | |
sales general and administrative to revenue | ||||||
shareholders equity per share | -0.00 - | 0.48 24,714.29% | 7.49 1,452.34% | 3.71 50.52% | 4.96 33.82% | |
stock based compensation to revenue | ||||||
tangible asset value | -21K - | 5.17M 24,714.29% | 178.78M 3,358.75% | 108.54M 39.29% | 169.24M 55.92% | |
tangible book value per share | -0.00 - | 0.48 24,714.29% | 7.49 1,452.34% | 3.71 50.52% | 4.96 33.82% | |
working capital | -21K - | 60.60M 288,690.48% | 171.92M 183.68% | 98.72M 42.58% | 156.32M 58.35% |
All numbers in USD (except ratios and percentages)